Ultragenyx Pharmaceutical (RARE) Exchange Rate Effect (2017 - 2026)
Ultragenyx Pharmaceutical (RARE) reported Exchange Rate Effect of -$1.0 million for Q1 2026, down 200.0% year-over-year from $1.0 million in Q1 2025, and down 52.44% on a QoQ basis from -$656000.0 in Q4 2025.
Ultragenyx Pharmaceutical (RARE) has 10 years of Exchange Rate Effect data on file, last reported at -$1.0 million in Q1 2026.
- Quarterly Exchange Rate Effect fell 200.0% year-over-year to -$1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (up 723.05% YoY) and the FY2025 annual result came in at $4.0 million, up 300.0% from the prior year.
- Exchange Rate Effect retreated to -$1.0 million in Q1 2026 per RARE's latest filing, from -$656000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $3.4 million in Q2 2025 and bottomed at -$1.9 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$136000.0 (2023), against an average of -$4411.8.
- The widest annual swing landed in 2024, when Exchange Rate Effect sank 421.8%; it then jumped 618.83% in 2025.
- Tracing RARE's Exchange Rate Effect over 5 years: stood at $1.4 million in 2022, then sank by 52.59% to $641000.0 in 2023, then sank by 403.9% to -$1.9 million in 2024, then surged by 66.32% to -$656000.0 in 2025, then slumped by 52.44% to -$1.0 million in 2026.
- Per Business Quant, the three latest RARE Exchange Rate Effect figures stand at -$1.0 million (Q1 2026), -$656000.0 (Q4 2025), and $294000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | -1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.00 Mn |
| Mar 31, 2026 | -1.00 Mn |
| Dec 31, 2025 | -656,000.00 |
| Dec 31, 2025 | -656,000.00 |
| Sep 30, 2025 | 294,000.00 |
| Sep 30, 2025 | 294,000.00 |
| Jun 30, 2025 | 3.36 Mn |
| Jun 30, 2025 | 3.36 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | -1.95 Mn |
| Dec 31, 2024 | -1.95 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | -648,000.00 |
| Jun 30, 2024 | -648,000.00 |
| Mar 31, 2024 | -679,000.00 |
| Mar 31, 2024 | -679,000.00 |
| Dec 31, 2023 | 641,000.00 |
| Dec 31, 2023 | 641,000.00 |
| Sep 30, 2023 | -716,000.00 |
| Sep 30, 2023 | -716,000.00 |
| Jun 30, 2023 | -136,000.00 |
| Jun 30, 2023 | -136,000.00 |
| Mar 31, 2023 | 211,000.00 |
| Mar 31, 2023 | 211,000.00 |
| Dec 31, 2022 | 1.35 Mn |
| Dec 31, 2022 | 1.35 Mn |
| Sep 30, 2022 | -1.08 Mn |
| Sep 30, 2022 | -1.08 Mn |
| Jun 30, 2022 | -1.24 Mn |
| Jun 30, 2022 | -1.24 Mn |
| Mar 31, 2022 | -108,000.00 |
| Mar 31, 2022 | -108,000.00 |
| Dec 31, 2021 | -392,000.00 |
| Dec 31, 2021 | -392,000.00 |
| Sep 30, 2021 | -479,000.00 |
| Sep 30, 2021 | -479,000.00 |
| Jun 30, 2021 | 448,000.00 |
| Jun 30, 2021 | 448,000.00 |
| Mar 31, 2021 | -771,000.00 |
| Mar 31, 2021 | -771,000.00 |
| Dec 31, 2020 | 880,000.00 |
| Dec 31, 2020 | 880,000.00 |
| Sep 30, 2020 | 437,000.00 |
| Sep 30, 2020 | 437,000.00 |
| Jun 30, 2020 | 425,000.00 |
| Jun 30, 2020 | 425,000.00 |
| Mar 31, 2020 | -623,000.00 |
| Mar 31, 2020 | -623,000.00 |
| Dec 31, 2019 | 337,000.00 |
| Dec 31, 2019 | 337,000.00 |
| Sep 30, 2019 | -472,000.00 |
| Sep 30, 2019 | -472,000.00 |
| Jun 30, 2019 | 168,000.00 |
| Jun 30, 2019 | 168,000.00 |
| Mar 31, 2019 | -198,000.00 |
| Mar 31, 2019 | -198,000.00 |
| Dec 31, 2018 | 145,000.00 |
| Dec 31, 2018 | 145,000.00 |
| Sep 30, 2018 | 30,000.00 |
| Sep 30, 2018 | 30,000.00 |
| Jun 30, 2018 | -896,000.00 |
| Jun 30, 2018 | -896,000.00 |
| Mar 31, 2018 | 249,000.00 |
| Mar 31, 2018 | 249,000.00 |
| Dec 31, 2017 | 361,000.00 |
| Dec 31, 2017 | 361,000.00 |
| Sep 30, 2017 | 528,000.00 |
| Sep 30, 2017 | 528,000.00 |
| Jun 30, 2017 | -378,000.00 |
| Jun 30, 2017 | -378,000.00 |
| Mar 31, 2017 | 17,000.00 |
| Mar 31, 2017 | 17,000.00 |